Wang C - Search Results

1

A batch-effect adjusted Simon's two-stage design for cancer vaccine clinical studies.

Wang C, Wang Z, Rosner GL, Huh WK, Roden RBS, Bae S. Wang C, et al. Among authors: wang z. Biometrics. 2021 Sep;77(3):1075-1088. doi: 10.1111/biom.13358. Epub 2020 Sep 10. Biometrics. 2021. PMID: 32822525 Free PMC article.

2

Phylogenetic considerations in designing a broadly protective multimeric L2 vaccine.

Jagu S, Kwak K, Schiller JT, Lowy DR, Kleanthous H, Kalnin K, Wang C, Wang HK, Chow LT, Huh WK, Jaganathan KS, Chivukula SV, Roden RB. Jagu S, et al. Among authors: wang hk, wang c. J Virol. 2013 Jun;87(11):6127-36. doi: 10.1128/JVI.03218-12. Epub 2013 Mar 27. J Virol. 2013. PMID: 23536682 Free PMC article.

3

Multivalent human papillomavirus l1 DNA vaccination utilizing electroporation.

Kwak K, Jiang R, Jagu S, Wang JW, Wang C, Christensen ND, Roden RB. Kwak K, et al. Among authors: wang jw, wang c. PLoS One. 2013;8(3):e60507. doi: 10.1371/journal.pone.0060507. Epub 2013 Mar 25. PLoS One. 2013. PMID: 23536912 Free PMC article.

4

Enhanced cancer radiotherapy through immunosuppressive stromal cell destruction in tumors.

Wu CY, Yang LH, Yang HY, Knoff J, Peng S, Lin YH, Wang C, Alvarez RD, Pai SI, Roden RB, Hung CF, Wu TC. Wu CY, et al. Among authors: wang c. Clin Cancer Res. 2014 Feb 1;20(3):644-57. doi: 10.1158/1078-0432.CCR-13-1334. Epub 2013 Dec 3. Clin Cancer Res. 2014. PMID: 24300786 Free PMC article.

5

Preparation and properties of a papillomavirus infectious intermediate and its utility for neutralization studies.

Wang JW, Jagu S, Kwak K, Wang C, Peng S, Kirnbauer R, Roden RB. Wang JW, et al. Among authors: wang c. Virology. 2014 Jan 20;449:304-16. doi: 10.1016/j.virol.2013.10.038. Epub 2013 Dec 20. Virology. 2014. PMID: 24418565 Free PMC article.

6

Measurement of neutralizing serum antibodies of patients vaccinated with human papillomavirus L1 or L2-based immunogens using furin-cleaved HPV Pseudovirions.

Wang JW, Jagu S, Wang C, Kitchener HC, Daayana S, Stern PL, Pang S, Day PM, Huh WK, Roden RB. Wang JW, et al. Among authors: wang c. PLoS One. 2014 Jul 7;9(7):e101576. doi: 10.1371/journal.pone.0101576. eCollection 2014. PLoS One. 2014. PMID: 24999962 Free PMC article.

7

Sequential cisplatin therapy and vaccination with HPV16 E6E7L2 fusion protein in saponin adjuvant GPI-0100 for the treatment of a model HPV16+ cancer.

Peng S, Wang JW, Karanam B, Wang C, Huh WK, Alvarez RD, Pai SI, Hung CF, Wu TC, Roden RB. Peng S, et al. Among authors: wang jw, wang c. PLoS One. 2015 Jan 5;10(1):e116389. doi: 10.1371/journal.pone.0116389. eCollection 2015. PLoS One. 2015. PMID: 25560237 Free PMC article.

8

A pilot study of pNGVL4a-CRT/E7(detox) for the treatment of patients with HPV16+ cervical intraepithelial neoplasia 2/3 (CIN2/3).

Alvarez RD, Huh WK, Bae S, Lamb LS Jr, Conner MG, Boyer J, Wang C, Hung CF, Sauter E, Paradis M, Adams EA, Hester S, Jackson BE, Wu TC, Trimble CL. Alvarez RD, et al. Among authors: wang c. Gynecol Oncol. 2016 Feb;140(2):245-52. doi: 10.1016/j.ygyno.2015.11.026. Epub 2015 Nov 23. Gynecol Oncol. 2016. PMID: 26616223 Free PMC article. Clinical Trial.

9

Nonparametric analysis of bivariate gap time with competing risks.

Huang CY, Wang C, Wang MC. Huang CY, et al. Among authors: wang mc, wang c. Biometrics. 2016 Sep;72(3):780-90. doi: 10.1111/biom.12494. Epub 2016 Mar 18. Biometrics. 2016. PMID: 26990686 Free PMC article.

10

Inference in randomized trials with death and missingness.

Wang C, Scharfstein DO, Colantuoni E, Girard TD, Yan Y. Wang C, et al. Biometrics. 2017 Jun;73(2):431-440. doi: 10.1111/biom.12594. Epub 2016 Oct 17. Biometrics. 2017. PMID: 27753071 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

101,850 results

Search Page